MIPLYM Trademark

Trademark Overview


On Thursday, December 12, 2019, a trademark application was filed for MIPLYM with the United States Patent and Trademark Office. The USPTO has given the MIPLYM trademark a serial number of 79279640. The federal status of this trademark filing is REGISTERED as of Tuesday, December 8, 2020. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The MIPLYM trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals

Pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes, namely, regenerative cell therapy preparations for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use

Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells

Scientific and medical research and development; scientific research services relating to the isolation and cultivation of human tissues and cells; analysis of human tissues and cells for medical research; cultivation of human cells for medical research; cultivation of cells for transplant taken from patients
miplym

General Information


Serial Number79279640
Word MarkMIPLYM
Filing DateThursday, December 12, 2019
Status700 - REGISTERED
Status DateTuesday, December 8, 2020
Registration Number6213622
Registration DateTuesday, December 8, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2020

Trademark Statements


Goods and ServicesCustom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals
Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes, namely, regenerative cell therapy preparations for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use
Goods and ServicesMedical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells
Goods and ServicesScientific and medical research and development; scientific research services relating to the isolation and cultivation of human tissues and cells; analysis of human tissues and cells for medical research; cultivation of human cells for medical research; cultivation of cells for transplant taken from patients

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Sunday, March 12, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 4, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 11, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 10, 2021FINAL DISPOSITION PROCESSED
Monday, March 8, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 8, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 8, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 24, 2020REFUSAL PROCESSED BY IB
Saturday, March 28, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 27, 2020REFUSAL PROCESSED BY MPU
Friday, March 13, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 12, 2020NON-FINAL ACTION WRITTEN
Thursday, March 12, 2020ASSIGNED TO EXAMINER
Friday, March 6, 2020APPLICATION FILING RECEIPT MAILED
Monday, March 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 28, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 27, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB